Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Granneman

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Journal of Chromatography|March 5, 1993
Enantioselective determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urine using high-performance liquid chromatographyZ Hussein, S Y Chu, G R Granneman
Journal of Chromatography|March 5, 1993
High-performance liquid chromatographic method for determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urineZ Hussein, S Y Chu, G R Granneman
Journal of Chromatography. B, Biomedical Applications|June 9, 1995
Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatographyM D Karol, G R Granneman, K Alexander
Antimicrobial Agents and Chemotherapy|November 1, 1986
Difloxacin metabolism and pharmacokinetics in humans after single oral dosesG R Granneman, K M Snyder, V S Shu
Clinical Pharmacokinetics|January 1, 1992
Effect of cimetidine on the pharmacokinetics of temafloxacinF Sörgel, G R Granneman, U Stephan, et al.
Hepatology (Baltimore, Md.)|November 1, 1984
The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studiesJ W Kesterson, G R Granneman, J M Machinist
Clinical Pharmacokinetics|January 1, 1995
Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatographyG R Granneman, R A Braeckman, K A Erdman
Biopharmaceutics & Drug Disposition|August 1, 1997
Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteersS L Wong, P Linnen, R Mack, et al.
Clinical Pharmacokinetics|January 1, 1995
Lack of pharmacokinetic interaction between zileuton and phenytoin in humansE Samara, J H Cavanaugh, D Mukherjee, et al.
Psychopharmacology|March 14, 1998
Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteersS L Wong, C Locke, J Staser, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Journal of Chromatography|March 5, 1993
Enantioselective determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urine using high-performance liquid chromatographyZ Hussein, S Y Chu, G R Granneman
Journal of Chromatography|March 5, 1993
High-performance liquid chromatographic method for determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urineZ Hussein, S Y Chu, G R Granneman
Journal of Chromatography. B, Biomedical Applications|June 9, 1995
Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatographyM D Karol, G R Granneman, K Alexander
Antimicrobial Agents and Chemotherapy|November 1, 1986
Difloxacin metabolism and pharmacokinetics in humans after single oral dosesG R Granneman, K M Snyder, V S Shu
Clinical Pharmacokinetics|January 1, 1992
Effect of cimetidine on the pharmacokinetics of temafloxacinF Sörgel, G R Granneman, U Stephan, et al.
Hepatology (Baltimore, Md.)|November 1, 1984
The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studiesJ W Kesterson, G R Granneman, J M Machinist
Clinical Pharmacokinetics|January 1, 1995
Determination of a new 5-lipoxygenase inhibitor, zileuton, and its inactive N-dehydroxylated metabolite in plasma by high performance liquid chromatographyG R Granneman, R A Braeckman, K A Erdman
Biopharmaceutics & Drug Disposition|August 1, 1997
Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavailability of sertindole in healthy volunteersS L Wong, P Linnen, R Mack, et al.
Clinical Pharmacokinetics|January 1, 1995
Lack of pharmacokinetic interaction between zileuton and phenytoin in humansE Samara, J H Cavanaugh, D Mukherjee, et al.
Psychopharmacology|March 14, 1998
Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteersS L Wong, C Locke, J Staser, et al.
Pageof 9